Home › Compare › GETR vs MRK

GETR vs MRK: Dividend Comparison 2026

GETR yields 200000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GETR wins by $4.911780474428384e+29M in total portfolio value
10 years
GETR
GETR
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full GETR calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — GETR vs MRK

📍 GETR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGETRMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GETR + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GETR pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GETR
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, GETR beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GETR + MRK for your $10,000?

GETR: 50%MRK: 50%
100% MRK50/50100% GETR
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GETR
Analyst Ratings
3
Buy
Consensus: Buy
Price Target
$1.50
+149900.0% upside vs current
Range: $1.50 — $1.50
Altman Z
-10.2
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GETR buys
0
MRK buys
0
No recent congressional trades found for GETR or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGETRMRK
Forward yield200000.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$4.911780474428384e+29M$30.7K ✓
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓$950.29
Total dividends collected$4.911464459982279e+29M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$1.50$128.54 ✓

Year-by-year: GETR vs MRK ($10,000, DRIP)

YearGETR PortfolioGETR Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,192$351.54+$20.00M → GETR
2$37,424,589,019$37,403,177,570.09$12,524$392.70+$37424.58M → GETR
3$65,416,215,188,220$65,376,170,877,969.18$14,015$438.65+$65416215.17M → GETR
4$106,868,230,495,008,900$106,798,235,144,757,520.00$15,682$489.96+$106868230494.99M → GETR
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$17,547$547.23+$163172871735896.84M → GETR
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$19,632$611.16+$232854599801468864.00M → GETR
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$21,963$682.53+$310570858137017057280.00M → GETR
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$24,571$762.18+$3.871481543016132e+23M → GETR
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$27,486$851.08+$4.510617497632811e+26M → GETR
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$30,745$950.29+$4.911780474428384e+29M → GETR

GETR vs MRK: Complete Analysis 2026

GETR — Stock

Getaround, Inc. operates an online marketplace for peer-to-peer car sharing. The company offers Getaround, a digital carsharing marketplace connects guests who want instant access to cars nearby 24/7 for a variety of use cases. It rents convertibles, minivan, luxury, cargo van, SUV/jeep, coupe/sedan, pickup truck, and hatchback/wagon. Getaround, Inc. was incorporated in 2009 and is based in San Francisco, California.

Full GETR Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this GETR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GETR vs SCHDGETR vs JEPIGETR vs OGETR vs KOGETR vs MAINGETR vs JNJGETR vs ABBVGETR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.